Crescent Biopharma, Inc. (CBIO)
12.18
+0.85
(+7.50%)
USD |
NASDAQ |
Mar 06, 16:00
12.18
0.00 (0.00%)
After-Hours: 20:00
Crescent Biopharma Cash from Investing (TTM) : -72.92M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| XOMA Royalty Corp. | -4.892M |
| Viridian Therapeutics, Inc. | -37.56M |
| DiaMedica Therapeutics, Inc. | -5.300M |
| Denali Therapeutics, Inc. | 255.28M |
| Praxis Precision Medicines, Inc. | -311.15M |